Ipamorelin IP2 2mg*10vials

Iparrelin IP2 2mg x 10 Vials

Product Overview

Iparrelin IP2 is a high-purity optimized lyophilized growth hormone-releasing pentapeptide, serving as an upgraded improved variant of classic iparrelin. IP2 supports higher receptor binding selectivity and superior anti-degradation stability research. It supports GHS-R1a growth hormone-releasing peptide receptor selective activation research, pituitary gland physiological pulsatile growth hormone release triggering studies, and cortisol and prolactin level minimal impact related studies. The 2mg dosage is suitable for fine-dose gradient studies, body composition mechanism studies, bone metabolism exploration, tissue repair models, and long-term preclinical experiments on the growth hormone axis. It serves as a high-value core research material in the growth hormone-related peptide series.

Core Research Functions

Pulsatile Secretion of Endogenous Growth Hormone Selective Stimulation: Supports endogenous growth hormone pulsatile secretion selective stimulation research, human body natural hormone release rhythm high mimicry studies.

Lean Tissue Protein Synthesis Pathways and Lipolysis Research: Supports lean tissue protein synthesis pathways research, lipolysis promotion studies, bone remodeling and tissue repair mechanisms research.

Off-Target Signal Interference Reduction and Clearer Experimental Results: Supports off-target signal interference further reduction research compared to traditional iparrelin, providing clearer experimental results research.

Body Composition Regulation and Age-Related Growth Hormone Axis Dysfunction Research: Supports body composition regulation research, age-related growth hormone axis dysfunction studies, bone metabolism disorders research, muscle repair models research, and synergistic peptide combination protocols validation research.

Stable Low-Interference Experimental Data for Growth Hormone-Releasing Peptide Receptor Signaling Research: Supports stable low-interference experimental data provision research for growth hormone-releasing peptide receptor signaling and downstream physiological effects exploration.

Laboratory studies have shown that iparrelin IP2 supports endogenous growth hormone pulsatile secretion selective stimulation research, human body natural hormone release rhythm high mimicry studies. It supports lean tissue protein synthesis pathways research, lipolysis promotion studies, bone remodeling and tissue repair mechanisms research. Compared to traditional iparrelin, the IP2 modification supports off-target signal interference further reduction research, providing clearer experimental results research. It provides stable low-interference experimental data for growth hormone-releasing peptide receptor signaling and downstream physiological effects exploration.

Core Product Advantages

IP2 Optimized Modification: Upgraded molecular modifications support GHS-R1a receptor affinity and molecular stability improvement research, non-specific signal noise reduction studies, providing a more reliable experimental phenotype compared to standard iparrelin research.

Highly Selective Growth Hormone Release Curve: Supports pulsatile growth hormone secretion driving research, cortisol and prolactin minimal impact related studies, significantly reducing confounding hormonal variables in research models research.

2mg Precision Lyophilized Packaging: Suitable for precise dose grouping, repeated-dose interventions, and long-term preclinical studies, facilitating protocol development and combination peptide research.

Pharmaceutical-Grade Lyophilization Process: Aseptic vacuum lyophilization process supports peptide activity full preservation research. Each batch undergoes high-performance liquid chromatography HPLC purity testing and is accompanied by a complete Certificate of Analysis COA, demonstrating low impurities and excellent batch-to-batch consistency research.

Standard 10-Bottle Packaging: 10 bottles per box, aseptically packaged, suitable for laboratory storage, university endocrinology projects, preclinical drug development, and bulk wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 2mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis COA.